Health Care & Life Sciences » Pharmaceuticals » Pharmaceutical and medical device recalls | Pharmaceutical industry financial penalties in U.S. by violation type 1991-2015

Pharmaceutical industry financial penalties in the United States 1991-2015, by violation type

Pharmaceutical industry financial penalties in the U.S. from 1991 to 2015, by type of violation (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data describes the amount of money the pharmaceutical industry in the United States had to pay in financial penalties from 1991 to 2015, by the type of violation. Over this time the pharmaceutical industry paid some 1.7 billion USD in financial penalties due to poor manufacturing practices in which they sold drug products that failed to meet FDA standards or specifications.

Unlawful promotion	11090
Overcharging government health programs	5059
Financial violations	3562
Monopoly practices	2121
Poor manufacturing practices	1720
Kickbacks	743
Concealing data	267
Environmental violations	232
Illegal distribution	67
Multiple violations	10887

Pharmaceutical industry financial penalties in the United States 1991-2015, by violation type

StatInvestor